Frequently Asked Questions

How does the Aimovig Ally Access Card work?
Take your Access Card enrollment confirmation notice (the enrollment approval page that contains your individually assigned card details and the pharmacist instructions) to your pharmacy along with a valid Aimovig® prescription. The Aimovig Ally Access Card provides two offers in one convenient card. The Bridge to Commercial Coverage Offer provides Aimovig® free for up to 12 doses while coverage is pursued. Once coverage is established, the same card may be used for the $5 Copay Offer which provides Aimovig® for $5 per month up to a maximum benefit of $3500 per year. Please see the Terms and Conditions for the full program details.

Can I sign up for the Aimovig Ally Access Card if I have no insurance or if I have Medicare Part D?
No, only patients with commercial insurance are eligible for the card. For further coverage assistance, Aimovig Ally can help you with information on other access and financial resources. If you have government insurance, (i.e., Medicare Part A or Medicare Part B) but are using a commercial insurance plan to cover your Aimovig® prescription, you may still be eligible for the Aimovig Ally Access Card program. Please call Aimovig Ally support team at 833-Aimovig (833-246-6844), Monday-Friday, 8:00 AM - 9:00 PM EST.

I received a message that I am ineligible for the Aimovig Ally Access Card.
If you feel you may be eligible or have any questions, contact the Aimovig Ally support team at 833-Aimovig (833-246-6844), Monday - Friday, 8:00 AM - 9:00 PM EST.

My health plan charges a co-insurance instead of a copay. Will the Aimovig Ally Access Card still help with my co-insurance costs?
Yes, the Aimovig Ally Access Card’s Copay Offer can help you lower co-insurance costs, deductibles, and/or copayments subject to the annual maximum benefit. Please see the Terms and Conditions for the full program details.

I already paid my copay in full. Can I get reimbursed?
You may be eligible for reimbursement. Reimbursement requests for the copay offer can be faxed to 908-809-6228 or mailed to Aimovig Ally Access Card c/o ConnectiveRx, PO Box 2355 Morristown, NJ 07962. Please include your receipt(s) and insurance information.

When I got my prescription filled I was told I need to have a prior authorization on file. How do I do that?
If necessary, your healthcare provider will be contacted to submit a prior authorization within 90 days of when you get your first prescription. If your coverage is denied, you remain eligible subject to ongoing eligibility requirements and program limits. If your healthcare provider obtains coverage, you will receive the copay offer.

How do I know if my healthcare provider has completed the prior authorization?
Your health plan typically notifies you of an approval or denial. Your healthcare provider should also receive a copy of this decision. We will contact your healthcare provider if we need them to confirm this information for determining your continued eligibility.

I was told I already had a prior authorization on file; what is the status?
Confirming this information may take up to 90 days. We will reach out to your healthcare provider if we need to confirm this information from them. If your coverage is denied, you remain eligible. If your healthcare provider obtains coverage, you will receive the copay offer.

I received a letter warning that I may be deactivated from the Bridge to Commercial Coverage Offer. What do I do?
You likely received this letter because we do not yet have any record that your healthcare provider is trying to obtain coverage for Aimovig® from your health plan. You may ask your healthcare provider if they have started this step. Once they have, they can provide us that information via a fax form. They can call 800-671-2709 and request a form to confirm they have submitted a prior authorization or medical exception request that resulted in a denial by your health plan. If they do not, the Bridge to Commercial Coverage Offer will be deactivated. It is a necessary condition of the offer that your healthcare provider works with your insurance provider in a reasonable amount of time on coverage. Please see the Terms and Conditions for the full program details.

Back


For more information about Aimovig® please visit: aimovig.com  | Privacy Policy  | Terms of Use

For more information about Aimovig please visit:   aimovig.com  | Privacy Policy  | Terms of Use

+

Important Safety Information

Who should not use Aimovig®?

Do not use Aimovig® if you are allergic to erenumab-aooe or any ingredients in Aimovig®.

Before starting Aimovig®, tell your healthcare provider (HCP) about all your medical conditions, including if you are allergic to rubber or latex, pregnant or plan to become pregnant, breastfeeding or plan to breastfeed.

Tell your HCP about all the medicines you take, including any prescription and over-the-counter medicines, vitamins, or herbal supplements.

What are possible side effects of Aimovig®?

Aimovig® may cause serious side effects, including:

  • Allergic reactions. Allergic reactions, including rash or swelling can happen after receiving Aimovig®. This can happen within hours to days after using Aimovig®. Call your HCP or get emergency medical help right away if you have any of the following symptoms of an allergic reaction: swelling of the face, mouth, tongue or throat, or trouble breathing.
  • Constipation with serious complications. Severe constipation can happen after receiving Aimovig®. In some cases people have been hospitalized or needed surgery. Contact your HCP if you have severe constipation.

The most common side effects of Aimovig® are pain, redness, or swelling at the injection site and constipation.

These are not all of the possible side effects of Aimovig®. Call your HCP for medical advice about side effects.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Click here for Full Prescribing Information and Patient Product Information.

Approved Use

Aimovig® (erenumab-aooe) is a prescription medicine used for the preventive treatment of migraine in adults.

  

© 2019 Amgen Inc. All rights reserved.

Amgen Inc.
One Amgen Center Drive, Thousand Oaks, CA 91320-1799

Novartis Pharmaceuticals Corp.
One Health Plaza, East Hanover, NJ 07936-1080                                                   




© 2019 Amgen Inc. All rights reserved.

Amgen Inc. One Amgen Center Drive,Thousand Oaks, CA 91320-1799

Novartis Pharmaceuticals Corp.
One Health Plaza, East Hanover, NJ 07936-1080